Gwynn Douglas Long, MD

Professor of Medicine
Campus mail Box 3961 Med Ctr, Durham, NC 27710
Phone (919) 668-1000
Email address gwynn.long@duke.edu

1. High dose therapy and autologous and allogeneic stem cell rescue for hematologic malignancies (especially multiple myeloma) and solid tumors.
2. Non-myeloablative allogeneic transplants for hematologic malignancies and solid tumors.
3. Supportive care for hematopoietic stem cell transplants.
4. Prevention and therapy of graft versus host disease.

Education and Training

  • Fellow in Medical Oncology, Medicine, Stanford University, 1987 - 1990
  • Medical Resident, Medicine, Vanderbilt University, 1983 - 1986
  • M.D., Wake Forest University, 1983
  • M.S., Wake Forest University, 1979

Publications

Maddox, L., G. D. Long, J. J. Vredenburgh, and R. J. Folz. “Rhizopus presenting as an endobronchial obstruction following bone marrow transplant..” Bone Marrow Transplant 28, no. 6 (September 2001): 634–36. https://doi.org/10.1038/sj.bmt.1703191.

PMID
11607783
Full Text

Bhagat, R., T. A. Sporn, G. D. Long, and R. J. Folz. “Amiodarone and cyclophosphamide: potential for enhanced lung toxicity..” Bone Marrow Transplant 27, no. 10 (May 2001): 1109–11. https://doi.org/10.1038/sj.bmt.1703039.

PMID
11438830
Full Text

Horning, S. J., R. S. Negrin, R. T. Hoppe, S. A. Rosenberg, N. J. Chao, G. D. Long, B. W. Brown, and K. G. Blume. “High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial..” Blood 97, no. 2 (January 15, 2001): 404–9. https://doi.org/10.1182/blood.v97.2.404.

PMID
11154216
Full Text

Stuart, M. J., N. S. Chao, S. J. Horning, R. M. Wong, R. S. Negrin, L. J. Johnston, J. A. Shizuru, G. D. Long, K. G. Blume, and K. E. Stockerl-Goldstein. “Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease..” Biol Blood Marrow Transplant 7, no. 10 (2001): 552–60.

PMID
11760087
Scholars@Duke

McGaughey, D. S., D. A. Nikcevich, G. D. Long, J. J. Vredenburgh, D. Rizzieri, C. A. Smith, G. Broadwater, et al. “Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation..” Biol Blood Marrow Transplant 7, no. 5 (2001): 274–78.

PMID
11400949
Scholars@Duke

Alvarnas, J. C., R. S. Negrin, S. J. Horning, W. W. Hu, G. D. Long, J. R. Schriber, K. Stockerl-Goldstein, et al. “High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma..” Biol Blood Marrow Transplant 6, no. 3A (2000): 352–58.

PMID
10905773
Scholars@Duke

Chao, N. J., D. S. Snyder, M. Jain, R. M. Wong, J. C. Niland, R. S. Negrin, G. D. Long, et al. “Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial..” Biol Blood Marrow Transplant 6, no. 3 (2000): 254–61.

PMID
10871150
Scholars@Duke

Hu, W. W., R. S. Negrin, K. Stockerl-Goldstein, L. J. Johnston, J. A. Shizuru, R. M. Wong, N. J. Chao, G. D. Long, R. H. Feiner, and K. G. Blume. “Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy..” Biol Blood Marrow Transplant 6, no. 1 (2000): 58–69.

PMID
10708000
Scholars@Duke

Stockerl-Goldstein, K. E., S. A. Reddy, S. F. Horning, K. G. Blume, N. F. Chao, W. W. Hu, L. F. Johnston, et al. “Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells..” Biol Blood Marrow Transplant 6, no. 5 (2000): 506–12.

PMID
11063379
Scholars@Duke

Hu, W. W., G. D. Long, K. E. Stockerl-Goldstein, L. J. Johnston, N. J. Chao, R. S. Negrin, and K. G. Blume. “A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer..” Clin Cancer Res 5, no. 11 (November 1999): 3411–18.

PMID
10589752
Scholars@Duke

Pages